Fernando Sabino, Medical Oncologist specializing in GU and GI tumors at Hospital Sírio-Libanês in Brazil, shared a post on X about a recent article he and colleagues authored:
“Are better days ahead in penile cancer? Just out in European Urology.”
Shilpa Gupta, Director of Genitourinary Oncology at the Cleveland Clinic, shared this post, adding:
“Congrats Fernando Sabino, Philippe Spiess, Matteo Santoni on this excellent editorial in European Urology.
Great to see progress in penile cancer with checkpoint inhibitors!”
Title: Re: Fernando Cotait Maluf, Karine Trindade, Daniel Preto, et al. Pembrolizumab plus Platinum-based Chemotherapy for Patients with Advanced Penile Cancer: The Nonrandomized HERCULES (LACOG 0218) Clinical Trial. JAMA Oncol. In press. https://doi.org/10.1001/jamaoncol.2025.3266
Authors: Fernando Sabino Marques Monteiro, Matteo Santoni, Philippe E. Spiess
Read the Full Article in European Urology.
More posts featuring Fernando Sabino on OncoDaily.
